Associations of HLA-A, HLA-B and HLA-C alleles frequency with prevalence of herpes simplex virus infections and diseases across global populations: Implication for the development of an universal CD8+ T-cell epitope-based vaccine

Human Immunology

Volumn 75, Issue 8, 2014, Pages 715-729

  Samandary, Sarah ^a   Kridane Miledi, Hédia ^b   Sandoval, Jacqueline S ^a   Choudhury, Zareen ^a   Langa Vives, Francina ^c   Spencer, Doran ^a   Chentoufi, Aziz A ^a,e   Lemonnier, François A ^b   BenMohamed, Lbachir ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HÔPITAL SAINT VINCENT DE PAUL   (France)

^c INSTITUT PASTEUR   (France)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e KING FAHAD MEDICAL CITY   (Saudi Arabia)

Author keywords

Alleles; Epitope; Frequency; Herpes Simplex Virus; HLA A; HLA B; HLA C; Prevalence; Vaccine

Indexed keywords

HERPES SIMPLEX VACCINE; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; EPITOPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLACK PERSON; CAUCASIAN; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; EYE DISEASE; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; HAPLOTYPE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HISPANIC; MALE; MOUSE; NONHUMAN; POPULATION; PREVALENCE; PRIORITY JOURNAL; AFRICA; ALLELE; ANIMAL; ASIA; EUROPE; GENE EXPRESSION; GENETICS; HERPES GENITALIS; HERPES LABIALIS; HUMAN; IMMUNOLOGY; T LYMPHOCYTE; TRANSGENIC MOUSE; VIROLOGY; WESTERN HEMISPHERE;

AFRICA; ALLELES; AMERICAS; ANIMALS; ASIA; EPITOPES, T-LYMPHOCYTE; EUROPE; GENE EXPRESSION; GENE FREQUENCY; HERPES GENITALIS; HERPES LABIALIS; HERPES SIMPLEX VIRUS VACCINES; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-C ANTIGENS; HUMANS; MICE; MICE, TRANSGENIC; PREVALENCE; T-LYMPHOCYTES;

EID: 84905122949     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2014.04.016     Document Type: Article

References (219)

1. Chentoufi A.A., Kritzer E., Yu D.M., Nesburn A.B., BenMohamed L. Towards a rational design of an asymptomatic clinical herpes vaccine: the old, the new, and the unknown. Clin Dev Immunol 2012, 2012:187585.
2. Awasthi S., Friedman H.M. Status of prophylactic and therapeutic genital herpes vaccines. Curr Opin Virol 2014, 6C:6.
3. Knipe D.M., Corey L., Cohen J.I., Deal C.D. Summary and recommendations from a national institute of allergy and infectious diseases (NIAID) workshop on "next generation herpes simplex virus vaccines". Vaccine 2014, 32:1561.
4. Looker K.J., Garnett G.P., Schmid G.P. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Organ 2008, 86:805.
5. Haddow L.J., Sullivan E.A., Taylor J., Abel M., Cunningham A.L., Tabrizi S., et al. Herpes simplex virus type 2 (HSV-2) infection in women attending an antenatal clinic in the South Pacific island nation of Vanuatu. Sex Transm Dis 2007, 34:258.
6. Smith J.S., Robinson N.J. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 2002, 186(Suppl. 1):S3.
7. Cunningham A.L., Taylor R., Taylor J., Marks C., Shaw J., Mindel A. Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey. Sex Transm Infect 2006, 82:164.
8. Mbopi-Keou F.X., Gresenguet G., Mayaud P., Weiss H.A., Gopal R., Matta M., et al. Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention. J Infect Dis 2000, 182:1090.
9. Ouedraogo A., Nagot N., Vergne L., Konate I., Weiss H.A., Defer M.C., et al. Impact of suppressive herpes therapy on genital HIV-1 RNA among women taking antiretroviral therapy: a randomized controlled trial. AIDS 2006, 20:2305.
10. Freeman E.E., Weiss H.A., Glynn J.R., Cross P.L., Whitworth J.A., Hayes R.J. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006, 20:73.
11. Chentoufi A.A., Dervillez X., Rubbo P.A., Kuo T., Zhang X., Nagot N., et al. Current trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2. Curr Trends Immunol 2012, 13:51.
12. Rubbo P.A., Tuaillon E., Nagot N., Chentoufi A.A., Bollore K., Reynes J., et al. HIV-1 infection impairs HSV-specific CD4(+) and CD8(+) T-cell response by reducing Th1 cytokines and CCR5 ligand secretion. J Acquir Immune Defic Syndr 2011, 58:9.
13. Chentoufi A.A., BenMohamed L. Mucosal herpes immunity and immunopathology to ocular and genital herpes simplex virus infections. Clin Dev Immunol 2012, 2012:149135.
14. Dasgupta G., BenMohamed L. Of mice and not humans: how reliable are animal models for evaluation of herpes CD8(+)-T cell-epitopes-based immunotherapeutic vaccine candidates?. Vaccine 2011, 29:5824.
15. Dasgupta G., Chentoufi A.A., Nesburn A.B., Wechsler S.L., BenMohamed L. New concepts in herpes simplex virus vaccine development: notes from the battlefield. Expert Rev Vaccines 2009, 8:1023.
16. Dasgupta G., Chentoufi A.A., Nesburn A.B., Wechsler S.L., BenMohamed L. New concepts in herpes simplex virus vaccine development: notes from the battlefield. Expert Rev Vaccines 2009, 8:1023.
17. Nesburn A.B., Bettahi I., Zhang X., Zhu X., Chamberlain W., Afifi R.E., et al. Topical/mucosal delivery of sub-unit vaccines that stimulate the ocular mucosal immune system. Ocul Surf 2006, 4:178.
18. Whitley R.J. Herpes simplex virus infections of women and their offspring: implications for a developed society. Proc Natl Acad Sci U S A 1994, 91:2441.
19. Westhoff G.L., Little S.E., Caughey A.B. Herpes simplex virus and pregnancy: a review of the management of antenatal and peripartum herpes infections. Obstet Gynecol Surv 2011, 66:629.
20. Corey L., Wald A., Patel R., Sacks S.L., Tyring S.K., Warren T., et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004, 350:11.
21. Conant M.A., Spicer D.W., Smith C.D. Herpes simplex virus transmission: condom studies. Sex Transm Dis 1984, 11:94.
22. Chentoufi A.A., BenMohamed L., Van De Perre P., Ashkar A.A. Immunity to ocular and genital herpes simplex viruses infections. Clin Dev Immunol 2012, 2012:732546.
23. Chentoufi A.A., Dasgupta G., Nesburn A.B., Bettahi I., Binder N.R., Choudhury Z.S., et al. Nasolacrimal duct closure modulates ocular mucosal and systemic CD4(+) T-cell responses induced following topical ocular or intranasal immunization. Clin Vaccine Immunol 2010, 17:342.
24. *0201) transgenic rabbit model for preclinical evaluation of human CD8+ T cell epitope-based vaccines against ocular herpes. J Immunol 2010, 184:2561.
25. Nesburn A.B., Bettahi I., Dasgupta G., Chentoufi A.A., Zhang X., You S., et al. Functional Foxp3+ CD4+ CD25(Bright+) "natural" regulatory T cells are abundant in rabbit conjunctiva and suppress virus-specific CD4+ and CD8+ effector T cells during ocular herpes infection. J Virol 2007, 81:7647.
26. Bettahi I., Nesburn A.B., Yoon S., Zhang X., Mohebbi A., Sue V., et al. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines. Invest Ophthalmol Vis Sci 2007, 48:4643.
27. Zhang X., Issagholian A., Berg E.A., Fishman J.B., Nesburn A.B., BenMohamed L. Th-cytotoxic T-lymphocyte chimeric epitopes extended by Nepsilon-palmitoyl lysines induce herpes simplex virus type 1-specific effector CD8+ Tc1 responses and protect against ocular infection. J Virol 2005, 79:15289.
28. Nesburn A.B., Ramos T.V., Zhu X., Asgarzadeh H., Nguyen V., BenMohamed L. Local and systemic B cell and Th1 responses induced following ocular mucosal delivery of multiple epitopes of herpes simplex virus type 1 glycoprotein D together with cytosine-phosphate-guanine adjuvant. Vaccine 2005, 23:873.
29. Hollenbach J.A., Thomson G., Cao K., Fernandez-Vina M., Erlich H.A., Bugawan T.L., et al. HLA diversity, differentiation, and haplotype evolution in Mesoamerican Natives. Hum Immunol 2001, 62:378.
30. Takahashi N., Tanabe K., Sugamori T., Sato M., Kitamura J., Sato H., et al. Association between Takayasu arteritis and ulcerative colitis - case report and review of serological HLA analysis. Med Sci Monit 2011, 17:CS81.
31. *5801 allele and allopurinol-induced Stevens Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. BMC Med Genet 2011, 12:118.
32. Huy N.T., Hamada M., Kikuchi M., Lan N.T., Yasunami M., Zamora J., et al. Association of HLA and post-schistosomal hepatic disorder: a systematic review and meta-analysis. Parasitol Int 2011, 60:347.
33. de Menthon M., Lavalley M.P., Maldini C., Guillevin L., Mahr A. HLA-B51/B5 and the risk of Behcet's disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum 2009, 61:1287.
34. Awata T. Association of HLA genes with IDDM: a review. Nihon Rinsho 1997, 55(Suppl.):370.
35. Marsh S.G., Albert E.D., Bodmer W.F., Bontrop R.E., Dupont B., Erlich H.A., et al. An update to HLA nomenclature, 2010. Bone Marrow Transplant 2010, 45:846.
36. Marsh S.G., Albert E.D., Bodmer W.F., Bontrop R.E., Dupont B., Erlich H.A., et al. Nomenclature for factors of the HLA system, 2010. Tissue Antigens 2010, 75:291.
37. Holdsworth R., Hurley C.K., Marsh S.G., Lau M., Noreen H.J., Kempenich J.H., et al. The HLA dictionary 2008: a summary of HLA-A, -B, -C, -DRB1/3/4/5, and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. Tissue Antigens 2009, 73:95.
38. NIH Allele Frequency. 2013. http://www.ncbi.nlm.nih.gov/projects/gv/mhc/.
39. Allele Frequency. 2013. http://www.allelefrequencies.net/default.asp.
40. Sulcebe G., Cuenod M., Sanchez-Mazas A., Tiercy J.M., Zhubi B., Shyti E., et al. Human leukocyte antigen-A, -B, -C, -DRB1 and -DQB1 allele and haplotype frequencies in an Albanian population from Kosovo. Int J Immunogenet 2013, 40:104.
41. Riccio M.E., Buhler S., Nunes J.M., Vangenot C., Cuenod M., Currat M., et al. 16(th) IHIW: analysis of HLA population data, with updated results for 1996 to 2012 workshop data (AHPD project report). Int J Immunogenet 2013, 40:21.
42. Sanchez-Mazas A., Vidan-Jeras B., Nunes J.M., Fischer G., Little A.M., Bekmane U., et al. Strategies to work with HLA data in human populations for histocompatibility, clinical transplantation, epidemiology and population genetics: HLA-NET methodological recommendations. Int J Immunogenet 2012, 39:459.
43. Zhang X., Castelli F.A., Zhu X., Wu M., Maillere B., BenMohamed L. Gender-dependent HLA-DR-restricted epitopes identified from herpes simplex virus type 1 glycoprotein D. Clin Vaccine Immunol 2008, 15:1436.
44. *0201-restricted CD8+ cytotoxic T lymphocyte epitopes identified from herpes simplex virus glycoprotein D. J Immunol 2008, 180:426.
45. Zhang X., Dervillez X., Chentoufi A.A., Badakhshan T., Bettahi I., BenMohamed L. Targeting the genital tract mucosa with a lipopeptide/recombinant adenovirus prime/boost vaccine induces potent and long-lasting CD8+ T cell immunity against herpes: importance of MyD88. J Immunol 2012, 189:4496.
46. Jiang X., Chentoufi A.A., Hsiang C., Carpenter D., Osorio N., BenMohamed L., et al. The herpes simplex virus type 1 latency-associated transcript can protect neuron-derived C1300 and Neuro2A cells from granzyme B-induced apoptosis and CD8 T-cell killing. J Virol 2011, 85:2325.
47. Chentoufi A.A., Kritzer E., Tran M.V., Dasgupta G., Lim C.H., Yu D.C., et al. The herpes simplex virus 1 latency-associated transcript promotes functional exhaustion of virus-specific CD8+ T cells in latently infected trigeminal ganglia: a novel immune evasion mechanism. J Virol 2011, 85:9127.
48. Chentoufi A.A., Kritzer E., Tran M.V., Dasgupta G., Lim C.H., Yu D.C., et al. The herpes simplex virus 1 latency-associated transcript promotes functional exhaustion of virus-specific CD8+ T cells in latently infected trigeminal ganglia: a novel immune evasion mechanism. J Virol 2011, 85:9127.
49. Allen S.J., Hamrah P., Gate D., Mott K.R., Mantopoulos D., Zheng L., et al. The role of LAT in increased CD8+ T cell exhaustion in trigeminal ganglia of mice latently infected with herpes simplex virus 1. J Virol 2011, 85:4184.
50. Allen S.J., Hamrah P., Gate D., Mott K.R., Mantopoulos D., Zheng L., et al. The role of LAT in increased CD8+ T cell exhaustion in trigeminal ganglia of mice latently infected with herpes simplex virus 1. J Virol 2011, 85:4184.
51. Jiang X., Chentoufi A.A., Hsiang C., Carpenter D., Osorio N., Benmohamed L., et al. The herpes simplex virus type 1 latency associated transcript (LAT) can protect neuronal derived C1300 and Neuro2A cells from Granzyme B induced apoptosis and CD8 T-cell killing. J Virol 2011, 85:2325.
52. Zhang X., Chentoufi A.A., Dasgupta G., Nesburn A.B., Wu M., Zhu X., et al. A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challenge. Mucosal Immunol 2009, 2:129.
53. Mott K.R., Chentoufi A.A., Carpenter D., BenMohamed L., Wechsler S.L., Ghiasi H. The role of a glycoprotein K (gK) CD8+ T-cell epitope of herpes simplex virus on virus replication and pathogenicity. Invest Ophthalmol Vis Sci 2009, 50:2903.
54. Mott K.R., Bresee C.J., Allen S.J., BenMohamed L., Wechsler S.L., Ghiasi H. Level of herpes simplex virus type 1 latency correlates with severity of corneal scarring and exhaustion of CD8+ T cells in trigeminal ganglia of latently infected mice. J Virol 2009, 83:2246.
55. Moraru M., Cisneros E., Gomez-Lozano N., de Pablo R., Portero F., Canizares M., et al. Host genetic factors in susceptibility to herpes simplex type 1 virus infection: contribution of polymorphic genes at the interface of innate and adaptive immunity. J Immunol 2012, 188:4412.
56. Lekstrom-Himes J.A., Hohman P., Warren T., Wald A., Nam J.M., Simonis T., et al. Association of major histocompatibility complex determinants with the development of symptomatic and asymptomatic genital herpes simplex virus type 2 infections. J Infect Dis 1999, 179:1077.
57. Bohringer D., Sundmacher R., Reinhard T. HLA B27 seems to promote graft failure following penetrating keratoplasties for herpetic corneal scars. Ophthalmologe 2007, 104:705.
58. Groothuis T.A., Griekspoor A.C., Neijssen J.J., Herberts C.A., Neefjes J.J. MHC class I alleles and their exploration of the antigen-processing machinery. Immunol Rev 2005, 207:60.
59. Klein J., Sato A. The HLA system. First of two parts. N Engl J Med 2000, 343:702.
60. Klein J., Sato A. The HLA system. Second of two parts. N Engl J Med 2000, 343:782.
61. Gonzalez-Galarza F.F., Christmas S., Middleton D., Jones A. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acid Res 2011, 39:D913.
62. Canossi A., Piancatelli D., Aureli A., Oumhani K., Ozzella G., Del Beato T., et al. Correlation between genetic HLA class I and II polymorphisms and anthropological aspects in the Chaouya population from Morocco (Arabic speaking). Tissue Antigens 2010, 76:177.
63. *1609 allele in the Moroccan Chaouya group. Tissue Antigens 2007, 69:367.
64. Piancatelli D., Canossi A., Aureli A., Oumhani K., Del Beato T., Di Rocco M., et al. Human leukocyte antigen-A, -B, and -Cw polymorphism in a Berber population from North Morocco using sequence-based typing. Tissue Antigens 2004, 63:158.
65. Oumhani K., Canossi A., Piancatelli D., Di Rocco M., Del Beato T., Liberatore G., et al. Sequence-Based analysis of the HLA-DRB1 polymorphism in Metalsa Berber and Chaouya Arabic-speaking groups from Morocco. Hum Immunol 2002, 63:129.
66. Lopez-Nevot M.A., Garcia E., Romero C., Oliva M.R., Serrano S., Garrido F. Phenotypic and genetic analysis of HLA class I and HLA-DR antigen expression on human melanomas. Exp Clin Immunogenet 1988, 5:203.
67. Ozawa M., Terasaki P.I., Lee J.H., Castro R., Alberu J., Alonso C., et al. 14th International HLA and immunogenetics workshop: report on the prospective chronic rejection project. Tissue Antigens 2007, 69(Suppl. 1):174.
68. Ozawa M., Terasaki P.I., Castro R., Alberu J., Morales-Buenrostro L., Alvarez I., et al. 14th International HLA and immunogenetics workshop prospective chronic rejection project: a three-year follow-up analysis. Clin Transpl 2007, 255.
69. El-Awar N., Lee J.H., Tarsitani C., Terasaki P.I. HLA class I epitopes: recognition of binding sites by mAbs or eluted alloantibody confirmed with single recombinant antigens. Hum Immunol 2007, 68:170.
70. Pekiner F.N., Aytugar E., Demirel G.Y., Borahan M.O. HLA-A, B (Class I) and HLA-DR, DQ (Class II) antigens in Turkish patients with recurrent aphthous ulceration and Behcet's disease. Med Princ Pract 2013, 22:464.
71. Castelli E.C., Gil D.S., Veiga L.C., de Camargo J.L. Typing class I HLA-A gene using a nested PCR-RFLP procedure. Braz J Med Biol Res 2005, 38:837.
72. *0201 with high affinity crossreact with other A2-supertype molecules. Hum Immunol 2001, 62:1200.
73. *4407 haplotype. Tissue Antigens 2006, 67:30.
74. Dupont E., Toungouz M., Andrien M., Vereerstraeten P. Compressive HLA matching. Nephrol Dial Transplant 1997, 12:2048.
75. Toungouz M., Denys C., Andrien M., De Groote D., Dupont E. Interleukin 12 unmasks HLA class I differences during mixed lymphocyte reaction induced interferon gamma production. Hum Immunol 1995, 44:145.
76. *7801 and seven additional alleles by BW6-specific exon 2 amplification. Tissue Antigens 1993, 42:480.
77. Andrien M., Stordeur P., Vamos E., Mascart Lemone F., Toungouz M., Monfils G., et al. Differential inducibility of HLA class I and II antigens by r-IFN gamma in type III bare lymphocyte syndrome. Transplant Proc 1991, 23:441.
78. *02:01-restricted epitopes from herpes simplex virus glycoprotein B preferentially recall polyfunctional CD8+ T cells from seropositive asymptomatic individuals and protect HLA transgenic mice against ocular herpes. J Immunol 2013, 191:5124.
79. Bunce M. PCR-sequence-specific primer typing of HLA class I and class II alleles. Methods Mol Biol 2003, 210:143.
80. Arrieta-Bolanos E., Maldonado-Torres H., Dimitriu O., Hoddinott M.A., Fowles F., Shah A., et al. HLA-A, -B, -C, -DQB1, and -DRB1,3,4,5 allele and haplotype frequencies in the Costa Rica central valley population and its relationship to worldwide populations. Hum Immunol 2011, 72:80.
81. Miao K.R., Pan Q.Q., Tang R.C., Zhou X.P., Fan S., Wang X.Y., et al. The polymorphism and haplotype analysis of HLA-A, -B and -DRB1 genes of population in Jiangsu province of China. Int J Immunogenet 2007, 34:419.
82. *. Tissue Antigens 2005, 66:248.
83. *24:137. Int J Immunogenet 2012, 39:530.
84. Rivino L., Tan A.T., Chia A., Kumaran E.A., Grotenbreg G.M., Macary P.A., et al. Defining CD8+ T Cell determinants during human viral infection in populations of Asian ethnicity. J Immunol 2013, 191:4010.
85. Fleischhauer K., Agostino A., Zino E., Mazzi B., Benazzi E., Arevalo-Herrera M., et al. Molecular characterization of HLA class I in Colombians carrying HLA-A2: high allelic diversity and frequency of heterozygotes at the HLA-B locus. Tissue Antigens 1999, 53:519.
86. *02 subtypes in Colombian Blacks and Mestizos. Tissue Antigens 1998, 51:204.
87. Pingel J., Solloch U.V., Hofmann J.A., Lange V., Ehninger G., Schmidt A.H. High-resolution HLA haplotype frequencies of stem cell donors in Germany with foreign parentage: how can they be used to improve unrelated donor searches?. Hum Immunol 2013, 74:330.
88. Pingel S., Weyer S., Galle P.R., Lohr H.F. Evolution of viral quasispecies in four dominant HlA-A2 restricted T cell epitopes is not a major reason for viral persistence in interferon-treated patients with chronic hepatitis C. J Med Virol 2002, 66:472.
89. Schmidt J., Neumann-Haefelin C., Altay T., Gostick E., Price D.A., Lohmann V., et al. Immunodominance of HLA-A2-restricted hepatitis C virus-specific CD8+ T cell responses is linked to naive-precursor frequency. J Virol 2011, 85:5232.
90. Dunne C., Crowley J., Hagan R., Rooney G., Lawlor E. HLA-A, B, Cw, DRB1, DQB1 and DPB1 alleles and haplotypes in the genetically homogenous Irish population. Int J Immunogenet 2008, 35:295.
91. *0114. Tissue Antigens 2007, 69:200.
92. McGuigan C., Dunne C., Crowley J., Hagan R., Rooney G., Lawlor E., et al. Population frequency of HLA haplotypes contributes to the prevalence difference of multiple sclerosis in Ireland. J Neurol 2005, 252:1245.
93. Middleton D., Williams F., Meenagh A., Daar A.S., Gorodezky C., Hammond M., et al. Analysis of the distribution of HLA-A alleles in populations from five continents. Hum Immunol 2000, 61:1048.
94. Bruges Armas J., Destro-Bisol G., Lopez-Vazquez A., Couto A.R., Spedini G., Gonzalez S., et al. HLA class I variation in the West African Pygmies and their genetic relationship with other African populations. Tissue Antigens 2003, 62:233.
95. Cao K., Moormann A.M., Lyke K.E., Masaberg C., Sumba O.P., Doumbo O.K., et al. Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci. Tissue Antigens 2004, 63:293.
96. *0201+ cytotoxic T cell line. J Immunol 1996, 157:787.
97. O'Hanlon T.P., Rider L.G., Mamyrova G., Targoff I.N., Arnett F.C., Reveille J.D., et al. HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies. Arthritis Rheum 2006, 54:3670.
98. Gao X., Single R.M., Karacki P., Marti D., O'Brien S.J., Carrington M. Diversity of MICA and linkage disequilibrium with HLA-B in two North American populations. Hum Immunol 2006, 67:152.
99. Klitz W., Gragert L., Maiers M., Tu B., Lazaro A., Yang R., et al. Four-locus high-resolution HLA typing in a sample of Mexican Americans. Tissue Antigens 2009, 74:508.
100. Maiers M., Gragert L., Klitz W. High-resolution HLA alleles and haplotypes in the United States population. Hum Immunol 2007, 68:779.
101. Xu F., Sternberg M.R., Markowitz L.E. Women who have sex with women in the United States: prevalence, sexual behavior and prevalence of herpes simplex virus type 2 infection-results from national health and nutrition examination survey 2001-2006. Sex Transm Dis 2010, 37:407.
102. Morishima Y., Sasazuki T., Inoko H., Juji T., Akaza T., Yamamoto K., et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood 2002, 99:4200.
103. Ali M.E., Ahmed M.U., Alam S., Rahman M.H. HLA-A, -B and -DRB1 allele frequencies in the Bangladeshi population. Tissue Antigens 2008, 72:115.
104. Olsson K.S., Ritter B., Raha-Chowdhury R. HLA-A3-B14 and the origin of the haemochromatosis C282Y mutation: founder effects and recombination events during 12 generations in a Scandinavian family with major iron overload. Eur J Haematol 2010, 84:145.
105. Smestad C., Brynedal B., Jonasdottir G., Lorentzen A.R., Masterman T., Akesson E., et al. The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients. Eur J Neurol 2007, 14:835.
106. *2312 - a novel allele found during testing for the UK NEQAS for H&I DNA HLA-typing scheme. Tissue Antigens 2006, 68:175.
107. *. Tissue Antigens 2004, 63:600.
108. *1405, detected by sequence based typing. Tissue Antigens 2002, 59:226.
109. Kippner L., Klint C., Sturfelt G., Bengtsson A.A., Eriksson H., Truedsson L. Increased level of soluble HLA class I antigens in systemic lupus erythematosus: correlation with anti-DNA antibodies and leukopenia. J Autoimmun 2001, 16:471.
110. Ottinger H.D., Ferencik S., Beelen D.W., Lindemann M., Peceny R., Elmaagacli A.H., et al. Impact of HLA-A, B, C allele mismatches on outcome after unrelated blood stem cell transplantation in whites. Transplantation 2004, 78:1077.
111. Kubens B.S., Ferencik S., Grosse-Wilde H. An HLA-A/C, B recombination detected by one-dimensional isoelectric focusing gel electrophoresis. Tissue Antigens 1991, 38:92.
112. Svejgaard A., Hauge M., Jersild C., Platz P., Ryder L.P., Nielsen L.S., et al. The HLA system. An introductory survey. Monogr Hum Genet 1975, 7:1.
113. Staub Nielsen L., Jersild C., Ryder L.P., Svejgaard A. HL-A antigen, gene, and haplotype frequencies in Denmark. Tissue Antigens 1975, 6:70.
114. Fleischhauer K., Kernan N.A., O'Reilly R.J., Dupont B., Yang S.Y. Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. N Engl J Med 1990, 323:1818.
115. Bera O., Cesaire R., Quelvennec E., Quillivic F., de Chavigny V., Ribal C., et al. HLA class I and class II allele and haplotype diversity in Martinicans. Tissue Antigens 2001, 57:200.
116. Schulman L.L., Weinberg A.D., McGregor C., Galantowicz M.E., Suciu-Foca N.M., Itescu S. Mismatches at the HLA-DR and HLA-B loci are risk factors for acute rejection after lung transplantation. Am J Respir Crit Care Med 1998, 157:1833.
117. Liu Z., Colovai A.I., Tugulea S., Reed E.F., Fisher P.E., Mancini D., et al. Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J Clin Invest 1996, 98:1150.
118. Harris P.E., Liu Z., Suciu-Foca N. MHC class II binding of peptides derived from HLA-DR 1. J Immunol 1992, 148:2169.
119. Igarashi M., Suciu-Foca N., Ferrone S. Differential expression of HLA-DR allospecificities on antigen specific T cell clones. Tissue Antigens 1987, 29:160.
120. Yunis E.J., Awdeh Z., Johnson A., Suciu-Foca N., Robinson M.A., Hartzman R., et al. Complotype genetic loci segregate more frequently with HLA-DR than with HLA-B. Immunogenetics 1985, 21:25.
121. Suciu-Foca N., Reed E., Rohowsky C., Lewison A., King D.W. Influence of race on the predictability of mixed lymphocyte culture identity by HLA-DR matching. Transplantation 1983, 35:35.
122. Bubnova M.G., Oganov R.G. Treatment of patients with arterial hypertension and other stroke risk factors in clinical practice. The PROGNOS program. Ter Arkh 2009, 81:19.
123. Williams F., Meenagh A., Darke C., Acosta A., Daar A.S., Gorodezky C., et al. Analysis of the distribution of HLA-B alleles in populations from five continents. Hum Immunol 2001, 62:645.
124. Middleton D., Williams F., Hamill M.A., Meenagh A. Frequency of HLA-B alleles in a Caucasoid population determined by a two-stage PCR-SSOP typing strategy. Hum Immunol 2000, 61:1285.
125. Williams F., Meenagh A., Maxwell A.P., Middleton D. Allele resolution of HLA-A using oligonucleotide probes in a two-stage typing strategy. Tissue Antigens 1999, 54:59.
126. *4403-carrying haplotypes. Hum Immunol 2004, 65:181.
127. *0807 in Brazilians. Transplant Proc 2004, 36:823.
128. Henry J.B., Hubbell C.A., Davis M.C., Fernandez-Vina M.A., Yunis E.J., Shrimpton A.E. A new HLA-A1 mutation: a novel, null variant allele. Am J Clin Pathol 2004, 122:185.
129. Flomenberg N., Baxter-Lowe L.A., Confer D., Fernandez-Vina M., Filipovich A., Horowitz M., et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 2004, 104:1923.
130. Mack S.J., Tu B., Lazaro A., Yang R., Lancaster A.K., Cao K., et al. HLA-A, -B, -C, and -DRB1 allele and haplotype frequencies distinguish Eastern European Americans from the general European American population. Tissue Antigens 2009, 73:17.
131. Tu B., Mack S.J., Lazaro A., Lancaster A., Thomson G., Cao K., et al. HLA-A, -B, -C, -DRB1 allele and haplotype frequencies in an African American population. Tissue Antigens 2007, 69:73.
132. Elbjeirami W.M., Abdel-Rahman F., Hussein A.A. Probability of finding an HLA-matched donor in immediate and extended families: the Jordanian experience. Biol Blood Marrow Transplant 2013, 19:221.
133. Yabuki K., Ota M., Goto K., Kimura T., Nomura E., Ohno S., et al. Triplet repeat polymorphism in the MICA gene in HLA-B27 positive and negative caucasian patients with ankylosing spondylitis. Hum Immunol 1999, 60:83.
134. Yabuki K., Ohno S., Mizuki N., Ando H., Tabbara K.F., Goto K., et al. HLA class I and II typing of the patients with Behcet's disease in Saudi Arabia. Tissue Antigens 1999, 54:273.
135. *5101 with Behcet's disease in Greece. Invest Ophthalmol Vis Sci 1999, 40:1921.
136. Wallace G.R., Verity D.H., Delamaine L.J., Ohno S., Inoko H., Ota M., et al. MIC-A allele profiles and HLA class I associations in Behcet's disease. Immunogenetics 1999, 49:613.
137. Mizuki N., Ota M., Katsuyama Y., Yabuki K., Ando H., Goto K., et al. Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behcet's disease. Arthritis Rheum 1999, 42:1961.
138. Jawdat D.M., Al Saleh S., Sutton P., Al Anazi H., Shubaili A., Tamim H., et al. Chances of finding an HLA-matched sibling: the Saudi experience. Biol Blood Marrow Transplant 2009, 15:1342.
139. Hajeer A.H., Sawidan F.A., Bohlega S., Saleh S., Sutton P., Shubaili A., et al. HLA class I and class II polymorphisms in Saudi patients with myasthenia gravis. Int J Immunogenet 2009, 36:169.
140. Roitberg-Tambur A., Witt C.S., Friedmann A., Safirman C., Sherman L., Battat S., et al. Comparative analysis of HLA polymorphism at the serologic and molecular level in Moroccan and Ashkenazi Jews. Tissue Antigens 1995, 46:104.
141. Maiers M. A community standard XML message format for sequencing-based typing data. Tissue Antigens 2007, 69(Suppl. 1):69.
142. Kollman C., Maiers M., Gragert L., Muller C., Setterholm M., Oudshoorn M., et al. Estimation of HLA-A, -B, -DRB1 haplotype frequencies using mixed resolution data from a National Registry with selective retyping of volunteers. Hum Immunol 2007, 68:950.
143. Hurley C.K., Maiers M., Marsh S.G., Oudshoorn M. Overview of registries, HLA typing and diversity, and search algorithms. Tissue Antigens 2007, 69(Suppl. 1):3.
144. Cano P., Klitz W., Mack S.J., Maiers M., Marsh S.G., Noreen H., et al. Common and well-documented HLA alleles: report of the Ad-Hoc committee of the American society for histocompatiblity and immunogenetics. Hum Immunol 2007, 68:392.
145. Machulla H.K., Batnasan D., Steinborn F., Uyar F.A., Saruhan-Direskeneli G., Oguz F.S., et al. Genetic affinities among Mongol ethnic groups and their relationship to Turks. Tissue Antigens 2003, 61:292.
146. Aizawa H., Kinouchi Y., Negoro K., Nomura E., Imai G., Takahashi S., et al. HLA-B is the best candidate of susceptibility genes in HLA for Japanese ulcerative colitis. Tissue Antigens 2009, 73:569.
147. *4415, two variant HLA-B alleles identified in the Omani population. Tissue Antigens 2000, 56:376.
148. *0720, identified in the Cuban population. Tissue Antigens 2001, 57:80.
149. *0724. Tissue Antigens 2001, 57:471.
150. Lee K.W., Oh D.H., Lee C., Yang S.Y. Allelic and haplotypic diversity of HLA-A, -B, -C, -DRB1, and -DQB1 genes in the Korean population. Tissue Antigens 2005, 65:437.
151. *260102, identified by sequence-based typing. Tissue Antigens 2005, 66:704.
152. *. Tissue Antigens 2005, 66:240.
153. *1120, identified by sequence-based typing. Tissue Antigens 2005, 66:141.
154. *3111 identified by sequence-based typing. Tissue Antigens 2005, 66:145.
155. *0612, identified by sequence-based typing. Tissue Antigens 2005, 66:330.
156. Modiano D., Luoni G., Petrarca V., Sodiomon Sirima B., De Luca M., Simpore J., et al. HLA class I in three West African ethnic groups: genetic distances from sub-Saharan and Caucasoid populations. Tissue Antigens 2001, 57:128.
157. O'Hanlon T.P., Carrick D.M., Arnett F.C., Reveille J.D., Carrington M., Gao X., et al. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles and motifs define clinicopathologic groups in caucasians. Medicine (Baltimore) 2005, 84:338.
158. *07:01 monochain transgenic/H-2 Class I null mice: novel versatile preclinical models of human T cell responses. J Immunol 2013, 191:583.
159. Gallina G., Cumbo V., Messina P., Caprera V., Lio D., Caruso C. Lack of correlation between HLA-B35 resistance against herpes labialis and antibody titers to HSV-1. Oral Surg Oral Med Oral Pathol 1989, 68:167.
160. Gallina G., Cumbo V., Messina P., Modica M.A., Caruso C. MHC-linked genetic factors (HLA-B35) influencing recurrent circumoral herpetic lesions. Dis Markers 1987, 5:191.
161. Grimaldi M.C., Crouau-Roy B., Contu L., Amoros J.P. Molecular variation of HLA class I genes in the Corsican population: approach to its origin. Eur J Immunogenet 2002, 29:101.
162. Grimaldi M.C., Crouau-Roy B., Amoros J.P., Cambon-Thomsen A., Carcassi C., Orru S., et al. West Mediterranean islands (Corsica, Balearic islands, Sardinia) and the Basque population: contribution of HLA class I molecular markers to their evolutionary history. Tissue Antigens 2001, 58:281.
163. Farjadian S., Naruse T., Kawata H., Ghaderi A., Bahram S., Inoko H. Molecular analysis of HLA allele frequencies and haplotypes in Baloch of Iran compared with related populations of Pakistan. Tissue Antigens 2004, 64:581.
164. Novitsky V., Flores-Villanueva P.O., Chigwedere P., Gaolekwe S., Bussman H., Sebetso G., et al. Identification of most frequent HLA class I antigen specificities in Botswana: relevance for HIV vaccine design. Hum Immunol 2001, 62:146.
165. Flores-Villanueva P.O., Hendel H., Caillat-Zucman S., Rappaport J., Burgos-Tiburcio A., Bertin-Maghit S., et al. Associations of MHC ancestral haplotypes with resistance/susceptibility to AIDS disease development. J Immunol 2003, 170:1925.
166. Diouf K., Sarr A.D., Eisen G., Popper S., Mboup S., Kanki P. Associations between MHC class I and susceptibility to HIV-2 disease progression. J Hum Virol 2002, 5:1.
167. Middleton D., Gonzalez F., Fernandez-Vina M., Tiercy J.M., Marsh S.G., Aubrey M., et al. A bioinformatics approach to ascertaining the rarity of HLA alleles. Tissue Antigens 2009, 74:480.
168. Sanchez-Velasco P., Gomez-Casado E., Martinez-Laso J., Moscoso J., Zamora J., Lowy E., et al. HLA alleles in isolated populations from North Spain: origin of the Basques and the ancient Iberians. Tissue Antigens 2003, 61:384.
169. Comas D., Mateu E., Calafell F., Perez-Lezaun A., Bosch E., Martinez-Arias R., et al. HLA class I and class II DNA typing and the origin of Basques. Tissue Antigens 1998, 51:30.
170. Comas D., Calafell F., Mateu E., Perez-Lezaun A., Bertranpetit J. HLA evidence for the lack of genetic heterogeneity in Basques. Ann Hum Genet 1998, 62:123.
171. Wakimoto A., Ohashi K., Koyama M., Kato M., Tsutsui T., Saji F., et al. Regulation of classical HLA class I genes in human choriocarcinoma cells by nuclear proteins binding to MHC class I regulatory elements. Am J Reprod Immunol 1995, 34:323.
172. Rendine S., Borelli I., Barbanti M., Sacchi N., Roggero S., Curtoni E.S. HLA polymorphisms in Italian bone marrow donors: a regional analysis. Tissue Antigens 1998, 52:135.
173. Itoh Y., Mizuki N., Shimada T., Azuma F., Itakura M., Kashiwase K., et al. High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population. Immunogenetics 2005, 57:717.
174. Lulli P., Mangano V.D., Onori A., Batini C., Luoni G., Sirima B.S., et al. HLA-DRB1 and -DQB1 loci in three West African ethnic groups: genetic relationship with sub-Saharan African and European populations. Hum Immunol 2009, 70:903.
175. Spinola H., Couto A.R., Peixoto M.J., Anagnostou P., Destro-Bisol G., Spedini G., et al. HLA class-I diversity in Cameroon: evidence for a north-south structure of genetic variation and relationships with African populations. Ann Hum Genet 2011, 75:665.
176. Chaux P., Luiten R., Demotte N., Vantomme V., Stroobant V., Traversari C., et al. Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1. J Immunol 1999, 163:2928.
177. Breckpot K., Heirman C., De Greef C., van der Bruggen P., Thielemans K. Identification of new antigenic peptide presented by HLA-Cw7 and encoded by several MAGE genes using dendritic cells transduced with lentiviruses. J Immunol 2004, 172:2232.
178. Velickovic Z.M., Delahunt B., Carter J.M. HLA-DRB1 and HLA-DQB1 polymorphisms in Pacific Islands populations. Tissue Antigens 2002, 59:397.
179. Velickovic Z.M., Carter J.M. HLA-DPA1 and DPB1 polymorphism in four Pacific Islands populations determined by sequencing based typing. Tissue Antigens 2001, 57:493.
180. *12032 allele. Tissue Antigens 2001, 58:97.
181. Szczerkowska Dobosz A., Rebala K., Szczerkowska Z., Nedoszytko B. HLA-C locus alleles distribution in patients from northern Poland with psoriatic arthritis-preliminary report. Int J Immunogenet 2005, 32:389.
182. Browning M.J., Madrigal J.A., Krausa P., Kowalski H., Allsopp C.E., Little A.M., et al. The HLA-A, B, C genotype of the class I negative cell line Daudi reveals novel HLA-A and -B alleles. Tissue Antigens 1995, 45:177.
183. Lopez-Alvarez M.R., Moya-Quiles M.R., Minguela A., Gil J., Miras M., Campillo J.A., et al. HLA-C matching and liver transplants: donor-recipient genotypes influence early outcome and CD8+KIR2D+ T-cells recuperation. Transplantation 2009, 88:S54.
184. *07 on acute rejection. Hum Immunol 2007, 68:51.
185. Campillo J.A., Martinez-Escribano J.A., Muro M., Moya-Quiles R., Marin L.A., Montes-Ares O., et al. HLA class I and class II frequencies in patients with cutaneous malignant melanoma from southeastern Spain: the role of HLA-C in disease prognosis. Immunogenetics 2006, 57:926.
186. Moya-Quiles M.R., Torio A., Muro M., Montes-Ares O., Marin L., Minguela A., et al. Impact of HLA-C on acute rejection in liver transplantation. Transplant Proc 2003, 35:1892.
187. Muro M., Marin L., Torio A., Moya-Quiles M.R., Minguela A., Rosique-Roman J., et al. HLA polymorphism in the Murcia population (Spain): in the cradle of the archaeologic Iberians. Hum Immunol 2001, 62:910.
188. Torio A., Sanchez-Guerrero I., Muro M., Herrero N., Pagan J., Minguela A., et al. Analysis of the phenotypic distribution of HLA class I and class II in atopic and non-atopic asthma patients. Eur J Immunogenet 2000, 27:81.
189. Ibrahim A.I., Kouwatli K.M., Obeid M.T. Frequency of herpes simplex virus in Syria based on type-specific serological assay. Saudi Med J 2000, 21:355.
190. *68:02-restricted Gag-specific CTL responses can drive selection pressure on HIV but are subdominant and ineffective. AIDS 2013, 27:1717.
191. Paximadis M., Minevich G., Winchester R., Schramm D.B., Gray G.E., Sherman G.G., et al. KIR-HLA and maternal-infant HIV-1 transmission in sub-Saharan Africa. PLoS ONE 2011, 6:e16541.
192. Yang S., Cao J. Theoretical analysis and computer simulation of fluorescence lifetime measurements. II. Contour length dependence of single polymers. J Chem Phys 2004, 121:572.
193. *03. Tissue Antigens 1999, 54:303.
194. Whitley R.J., Lentnek A., McCracken G.H., Sande M.A., Scheld W.M. Evaluation of new anti-infective drugs for the treatment of viral encephalitis. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992, 15(Suppl. 1):S195.
195. Queiro R., Gonzalez S., Lopez-Larrea C., Alperi M., Sarasqueta C., Riestra J.L., et al. HLA-C locus alleles may modulate the clinical expression of psoriatic arthritis. Arthritis Res Ther 2006, 8:R185.
196. Martinez-Borra J., Brautbar C., Gonzalez S., Enk C.D., Lopez-Vazquez A., Lopez-Larrea C. The region of 150kb telomeric to HLA-C is associated with psoriasis in the Jewish population. J Invest Dermatol 2005, 125:928.
197. Martinez-Borra J., Gonzalez S., Santos-Juanes J., Sanchez del Rio J., Torre-Alonso J.C., Lopez-Vazquez A., et al. Psoriasis vulgaris and psoriatic arthritis share a 100kb susceptibility region telomeric to HLA-C. Rheumatology (Oxford) 2003, 42:1089.
198. Colin J., Chastel C., Saleun J.P., Morin J.F., Renard G. Recurrent ocular herpes simplex infection and HLA antigens; preliminary results (author's transl). J Fr Ophtalmol 1979, 2:263.
199. Meyers-Elliott R.H., Elliott J.H., Maxwell W.A., Pettit T.H., O'Day D.M., Terasaki P.I., et al. HLA antigens in recurrent stromal herpes simplex virus keratitis. Am J Ophthalmol 1980, 89:54.
200. Nunes J.M., Riccio M.E., Buhler S., Di D., Currat M., Ries F., et al. Analysis of the HLA population data (AHPD) submitted to the 15th International Histocompatibility/Immunogenetics Workshop by using the Gene[rate] computer tools accommodating ambiguous data (AHPD project report). Tissue Antigens 2010, 76:18.
201. Sulcebe G., Sanchez-Mazas A., Tiercy J.M., Shyti E., Mone I., Ylli Z., et al. HLA allele and haplotype frequencies in the Albanian population and their relationship with the other European populations. Int J Immunogenet 2009, 36:337.
202. BenMohamed L., Belkaid Y., Loing E., Brahimi K., Gras-Masse H., Druilhe P. Systemic immune responses induced by mucosal administration of lipopeptides without adjuvant. Eur J Immunol 2002, 32:2274.
203. BenMohamed L., Krishnan R., Auge C., Primus J.F., Diamond D.J. Intranasal administration of a synthetic lipopeptide without adjuvant induces systemic immune responses. Immunology 2002, 106:113.
204. BenMohamed L., Wechsler S.L., Nesburn A.B. Lipopeptide vaccines - yesterday, today, and tomorrow. Lancet Infect Dis 2002, 2:425.
205. Zhu X., Ramos T.V., Gras-Masse H., Kaplan B.E., BenMohamed L. Lipopeptide epitopes extended by Ne-palmitoyl lysine moiety increases uptake and maturation of dendritic cell through a toll-like receptor 2 pathway and triggers a th1-dependent protective immunity. Eur J Immunol 2004, 34:1142.
206. Sette A., Newman M., Livingston B., McKinney D., Sidney J., Ishioka G., et al. Optimizing vaccine design for cellular processing, MHC binding and TCR recognition. Tissue Antigens 2002, 59:443.
207. Rao X., Hoof I., Costa A.I., van Baarle D., Kesmir C. HLA class I allele promiscuity revisited. Immunogenetics 2011, 63:691.
208. Paul S., Weiskopf D., Angelo M.A., Sidney J., Peters B., Sette A. HLA Class I alleles are associated with peptide-binding repertoires of different size, affinity, and immunogenicity. J Immunol 2013, 191:5813.
209. *0702 transgenic, H-2KbDb double-knockout mice: phenotypical and functional characterization in response to influenza virus. Int Immunol 2003, 15:765.
210. Pascolo S., Bervas N., Ure J.M., Smith A.G., Lemonnier F.A., Perarnau B. HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice. J Exp Med 1997, 185:2043.
211. Sudenga S.L., Kempf M.C., McGwin G., Wilson C.M., Hook E.W., Shrestha S S. Incidence, prevalence, and epidemiology of herpes simplex virus-2 in HIV-1-positive and HIV-1-negative adolescents. Sex Transm Dis 2012, 39:300.
212. Patel P., Bush T., Mayer K.H., Desai S., Henry K., Overton E.T., et al. Prevalence and risk factors associated with herpes simplex virus-2 infection in a contemporary cohort of HIV-infected persons in the United States. Sex Transm Dis 2012, 39:154.
213. Wang C.C., Yepes L.C., Danaher R.J., Berger J.R., Mootoor Y., Kryscio R.J., et al. Low prevalence of varicella zoster virus and herpes simplex virus type 2 in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010, 109:232.
214. Tobian A.A., Charvat B., Ssempijja V., Kigozi G., Serwadda D., Makumbi F., et al. Factors associated with the prevalence and incidence of herpes simplex virus type 2 infection among men in Rakai, Uganda. J Infect Dis 2009, 199:945.
215. Hill J.M., Ball M.J., Neumann D.M., Azcuy A.M., Bhattacharjee P.S., Bouhanik S., et al. The high prevalence of herpes simplex virus type 1 DNA in human trigeminal ganglia is not a function of age or gender. J Virol 2008, 82:8230.
216. Clark J.L., Konda K.A., Munayco C.V., Pun M., Lescano A.G., Leon S.R., et al. Prevalence of HIV, herpes simplex virus-2, and syphilis in male sex partners of pregnant women in Peru. BMC Public Health 2008, 8:65.
217. Abu-Raddad L.J., Magaret A.S., Celum C., Wald A., Longini I.M., Self S.G., et al. Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PLoS ONE 2008, 3:e2230.
218. Xu F., Markowitz L.E., Sternberg M.R., Aral S.O. Prevalence of circumcision and herpes simplex virus type 2 infection in men in the United States: the National Health and Nutrition Examination Survey (NHANES), 1999-2004. Sex Transm Dis 2007, 34:479.
219. Tassiopoulos K.K., Seage G., Sam N., Kiwelu I., Shao J., Ao T.T., et al. Predictors of herpes simplex virus type 2 prevalence and incidence among bar and hotel workers in Moshi, Tanzania. J Infect Dis 2007, 195:493.